Back
Guidewire Software Vs. Kymera Therapeutics Industry Stock Comparison
Buy
62
GWRE
Guidewire Software
Last Price:
$235.82
Seasonality Move:
9.89%
Buy
80
KYMR
Kymera Therapeutics
Last Price:
$46.43
Seasonality Move:
30.84%
Buy
62
Guidewire Software (GWRE)
is a Buy
Is Guidewire Software a Buy, Sell or Hold?
-
The current Guidewire Software [GWRE] share price is $237.45. The Score for GWRE is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
GWRE is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
80
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
-
The current Kymera Therapeutics [KYMR] share price is $47.14. The Score for KYMR is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
-
KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GWRE Stock Price Chart
What is Guidewire Software's stock price today?
-
The Guidewire Software share price today is $237.45The current trend is moderately bearish and GWRE is experiencing selling pressure, which indicates risk of future bearish movement.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $47.14The current trend is moderately bullish and KYMR is experiencing slight buying pressure.
GWRE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 7.66 | Buy |
Relative Strength Index (14 RSI): | 54.01 | Buy |
Chaikin Money Flow: | -618065 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (214.05 - 252.29) | Buy |
Bollinger Bands (100): | (187.23 - 228.67) | Buy |
KYMR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.72 | Buy |
Relative Strength Index (14 RSI): | 70.29 | Buy |
Chaikin Money Flow: | 205476 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (32.36 - 48.58) | Buy |
Bollinger Bands (100): | (27.26 - 40.98) | Buy |
GWRE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 245.76 | Sell |
20-day SMA: | 238.48 | Sell |
50-day SMA: | 218.28 | Buy |
200-day SMA: | 194.82 | Buy |
8-day EMA: | 242.79 | Sell |
20-day EMA: | 238.17 | Sell |
50-day EMA: | 223.48 | Buy |
200-day EMA: | 192.68 | Buy |
KYMR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 46.65 | Buy |
20-day SMA: | 43.02 | Buy |
50-day SMA: | 35.36 | Buy |
200-day SMA: | 39.6 | Buy |
8-day EMA: | 46.37 | Buy |
20-day EMA: | 43.3 | Buy |
50-day EMA: | 38.2 | Buy |
200-day EMA: | 37.1 | Buy |
Guidewire Software Earnings Growth & GWRE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.21 per share, an increase next quarter of $0.16 per share, an increase this year of $1.12 per share, and an increase next year of $0.39 per share.
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.22 per share, a decrease this year of $0.76 per share, and a decrease next year of $0.40 per share.
Guidewire Software Technical Analysis
Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | Jun 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
10 | 11 | 12 | 13 | 16 | 17 | 18 | 20 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Kymera Therapeutics Technical Analysis
Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | Jun 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
10 | 11 | 12 | 13 | 16 | 17 | 18 | 20 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |